Table 1.
Patient demographics and clinical history.
| PCI (%) | CABG (%) | P | |
|---|---|---|---|
| BASELINE CHARACTERISTICS | |||
| Male/female (%) | 18 (81.8)/4 (18.2) | 13 (81.3)/3 (18.7) | NS |
| Age (years)# | 62.5 ± 9.9 | 64.9 ± 8.8 | NS |
| BMI (kg/m2) | 27.5 ± 3.9 | 27.3 ± 4.6 | NS |
| Waist circumference (cm) | 98.1 ± 10.3 | 97.5 ± 12.0 | NS |
| HISTORY | |||
| Past cardiac surgery (%) | 1 (4.5) | 3 (18.8) | NS |
| Myocardial infarction (%) | 11 (50.0) | 5 (31.3) | NS |
| Hypertension (treated) (%) | 8 (36.4) | 10 (62.5) | NS |
| Valvular disease (%) | 0 (0.0) | 3 (18.8) | NS |
| Arrhythmia (%) AF** | 1 (4.5) | 3 (18.8) | NS |
| Diabetes (%) | 5 (22.7) | 1 (6.3) | NS |
| Hyperlipidaemia (%) | 17 (77.2) | 14 (87.5) | NS |
| Stroke (%) | 2 (9.1) | 1 (6.3) | NS |
| Kidney problem (%) | 1 (4.5) | 1 (6.3) | NS |
| Family history (%) | 14 (63.6) | 15 (93.8) | NS |
| Smoker/ex smokers (%) | 1 (4.5)/8 (36.4) | 0 (0.0)/3 (18.8) | NS |
| Depression (%) | 6 (27.3) | 4 (25.0) | NS |
| MEDICATION | |||
| β-blockers/Stopped (%) | 11 (50.0)/1 (4.5) | 8 (50.0)/2 (12.5) | NS |
| Calcium antagonists (%) | 0 (0.0) | 1 (6.3) | NS |
| Diuretics (%) | 2 (9.1) | 2 (12.5) | NS |
| Angiotensin converting enzyme inhibitors | 14 (63.6) | 4 (25.0) | 0.025* |
| Antiplatelet treatment/bleeding | 22 (100.0)/1 (4.5) | 16 (100.0)/0 (0.0) | NS |
#
Mean and standard deviation;
*
PCI vs. CABG p < 0.05;
**
Atrial fibrillation.